We are the largest CRO specializing in Environmental Exposure Chamber (EEC) studies responsible for conducting over 70% of the EEC studies world-wide.
Toronto, ON (PRWEB) February 19, 2015
Inflamax Research, Inc., a specialized full service CRO and leader in clinical research in allergy and respiratory disease, today unveiled a new brand identity. The introduction of a new brand and logo signifies the growth and transformation, and celebrates the culture of innovation that has made Inflamax a world leader in allergy and respiratory clinical research.
“The new graphics better reflect our company and our services to the pharmacological community. Since our launch in 2012 we have grown substantially, and the new branding and logo better reflect that success.” said Dr. Piyush Patel, CEO and Medical Director of Inflamax Research. “Over the last three years we have experienced a great demand for our unique expertise as the world leader in allergy and respiratory research. We are the largest CRO specializing in Environmental Exposure Chamber (EEC) studies responsible for conducting over 70% of the EEC studies world-wide. We operate the largest EEC facility in the world with 7 fixed and mobile chambers in our Mississauga facility as well as mobile EEC units at locations throughout the world. We have invested heavily in both infrastructure and talent to make Inflamax Research the best in the world at clinical research, in allergy and respiratory research from proof of concept through late phase trials.”
The new logo and color palette draw on the strong foundation of Inflamax Research. The image has four branches, symbolic of the scientific method. Those branches have an organic shape to suggest the organic nature of their mission. There is also a human shape to it, reflecting the focus on advancing human medicine and service to our volunteers. The new colors are bold and solid, like the science behind the research.